fda regulations tirzepatide 📢Important Update on Compounded Tirzepatide! Due to recent FDA regulations, the compounding of is being impacted. But don't worry—we're here to help you navigate this change and ensure you stay Oral Tirzepatide Pill: FDA Status

Online telehealth for GLP-1 weight loss, TRT, HRT and IV therapy

This guide explores the clinical evidence, biomarker considerations, and how providers evaluate safety when considering GLP-1 therapy for patients with inflammatory bowel disease

Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population.

OSA affects an estimated 936 million people worldwide and is often linked to obesity and cardiometabolic risks.

Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces

Each year, the KFF conducts an Employer Health Benefits Survey to examine trends in employer-sponsored health benefits.